SlideShare a Scribd company logo
1 of 2
Download to read offline
Real-World & Late Phase Research
The right approach
for the right question
Observational research
& registries
Initiatives
AHRQ Registries User’s Guide –
www.effectivehealthcare.ahrq.gov
Quintiles leads the development of the
Agency for Healthcare Research and
Quality (AHRQ) user’s guide, Registries
for Evaluating Patient Outcomes.
AHRQ OCER User’s Guide –
www.effectivehealthcare.ahrq.gov
Quintiles leads the development of
AHRQ user’s guide, Developing a
Protocol for Observational Comparative
Effectiveness Research.
GRACE Principles –
www.graceprinciples.org (Good
ReseArch for Comparative Effectiveness)
Quintiles develops quality evaluation
principles for observational research.
ROPR (Registry of Patient Registries)
Quintiles leads the effort to create a
central index of patient registries.
ENCePP®
– www.encepp.eu
(European Network of Centres for
Pharmacoepidemiology and
Pharmacovigilance)
Quintiles assists the monitoring of
post-market medical products in Europe.
PROTECT-EU – www.imi-protect.eu
(Pharmacoepidemiological Research on
Outcomes of Therapeutics by a
European ConsorTium)
Quintiles helps develop innovative
methods in pharmacoepidemiology and
pharmacovigilance.
ASTER-D (Adverse Event Spontaneous
Triggered Electronic Reports for Devices)
Quintiles participates in a pilot approach
to collecting and transmitting adverse
event data electronically.
Connecting
insights
950 Medical Doctors
900 PhDs
13 Therapeutic Centers
of Excellence
Superior
delivery
Quintiles named as
Phase IV industry leader
in ISR 2014 report amongst
CRO Quality Benchmarking
Phase IV Service Providers
Better
outcomes
Quintiles helped develop or
commercialize 100% of the
Top 100 best-selling products
or compounds of 2013
Quintiles is a Fortune 500
company
Embrace
value-based
healthcare
Turn clinical evidence and
patient insight into a clear and
convincing value story
Maximize
commercial
value
Achieve and sustain peak
commercialization faster
through better market access
and channel strategies
Achieve
better patient
outcomes
Improve patient care using
real-world measures and
engagement
Access global
scale with local
knowledge
Leverage the industry’s
largest integrated service
infrastructure to gain local
insight and market access
Access to
>18M
Electronic
Health Records
through the COMPASS
network
Observational studies and
quality improvement
programs across
>70,000
sites since 2004
Performed quality
measurements for
13 patient
associations
and medical specialty
associations since 2001
Quintiles has worked on
41 rare
disease
registries
since 2004
Access to
>61M
patient lives
via Electronic Health
Records since 2004
125
patient
registries
and observational
studies since 2011
>14.7M
patients
in observational
and quality improvement
programs in >100
countries since 2004
>2,500
hospitals
in the American Heart
Association's Get With
The Guidelines®
quality
improvement program
>400
direct-to-
patient studies
in >30 countries since 2008
>500
Real-World
& Late Phase
Programs
since 2011
Experience of
44 post-
authorization
safety studies
(PASS)
>32,000
employees
operating in more than
100 countries
>14,500
HTA data
records
captured from 100 agencies
in 32 countries
Quintiles was named to
InformationWeek
Top 500 list
of Information Technology
Innovators for five
consecutive years
Quintiles has helped
gain market access for
>135
products
in the U.S. since 2003
Copyright©2015Quintiles.Allrightsreserved.19.0011-1-02.15

More Related Content

What's hot

Marketing Summary - sales presentatioin
Marketing Summary - sales presentatioinMarketing Summary - sales presentatioin
Marketing Summary - sales presentatioinMichael Passanante
 
UK AMR Diagnositics Collaborative
UK AMR Diagnositics CollaborativeUK AMR Diagnositics Collaborative
UK AMR Diagnositics CollaborativeWalt Whitman
 
Cortellis for CTI Message Platform
Cortellis for CTI Message PlatformCortellis for CTI Message Platform
Cortellis for CTI Message PlatformMichael Passanante
 
Risk management plans - proposed changes
Risk management plans - proposed changesRisk management plans - proposed changes
Risk management plans - proposed changesTGA Australia
 
Supply Point - Pharmacy Presentation
Supply Point - Pharmacy PresentationSupply Point - Pharmacy Presentation
Supply Point - Pharmacy PresentationIan Chisholm
 
Katherine Ward - ECO14: Patient Safety
Katherine Ward - ECO14: Patient SafetyKatherine Ward - ECO14: Patient Safety
Katherine Ward - ECO14: Patient SafetyInnovation Agency
 
Meaningful Use: Menu Set Measures
Meaningful Use: Menu Set MeasuresMeaningful Use: Menu Set Measures
Meaningful Use: Menu Set MeasuresGreenway Health
 
HSPA 20150505 bernal-delgado ECHO Project
HSPA 20150505 bernal-delgado ECHO ProjectHSPA 20150505 bernal-delgado ECHO Project
HSPA 20150505 bernal-delgado ECHO ProjectAtlas VPM
 
Dentists and Meaningful Use: An Update
Dentists and Meaningful Use: An UpdateDentists and Meaningful Use: An Update
Dentists and Meaningful Use: An UpdateGreenway Health
 
Antenatal programme updates
Antenatal programme updatesAntenatal programme updates
Antenatal programme updatesAndrew Anderson
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Covance
 
SPHS at the IPC Group Meeting, USA
SPHS at the IPC Group Meeting, USASPHS at the IPC Group Meeting, USA
SPHS at the IPC Group Meeting, USAUN SPHS
 
ART At Cost Program
ART At Cost ProgramART At Cost Program
ART At Cost ProgramMin Zaw
 
Intralign Rep-less Program
Intralign Rep-less ProgramIntralign Rep-less Program
Intralign Rep-less ProgramIntralign
 
Healthcare ERP Systems
Healthcare ERP SystemsHealthcare ERP Systems
Healthcare ERP SystemsMazik Global
 
Building a Social Future for NCI Trials (W. Lawton)
Building a Social Future for NCI Trials (W. Lawton)Building a Social Future for NCI Trials (W. Lawton)
Building a Social Future for NCI Trials (W. Lawton)Esmeralda Casas-Silva, Ph.D.
 

What's hot (20)

Marketing Summary - sales presentatioin
Marketing Summary - sales presentatioinMarketing Summary - sales presentatioin
Marketing Summary - sales presentatioin
 
UK AMR Diagnositics Collaborative
UK AMR Diagnositics CollaborativeUK AMR Diagnositics Collaborative
UK AMR Diagnositics Collaborative
 
Cortellis for CTI Message Platform
Cortellis for CTI Message PlatformCortellis for CTI Message Platform
Cortellis for CTI Message Platform
 
Risk management plans - proposed changes
Risk management plans - proposed changesRisk management plans - proposed changes
Risk management plans - proposed changes
 
Supply Point - Pharmacy Presentation
Supply Point - Pharmacy PresentationSupply Point - Pharmacy Presentation
Supply Point - Pharmacy Presentation
 
Katherine Ward - ECO14: Patient Safety
Katherine Ward - ECO14: Patient SafetyKatherine Ward - ECO14: Patient Safety
Katherine Ward - ECO14: Patient Safety
 
Meaningful Use: Menu Set Measures
Meaningful Use: Menu Set MeasuresMeaningful Use: Menu Set Measures
Meaningful Use: Menu Set Measures
 
HSPA 20150505 bernal-delgado ECHO Project
HSPA 20150505 bernal-delgado ECHO ProjectHSPA 20150505 bernal-delgado ECHO Project
HSPA 20150505 bernal-delgado ECHO Project
 
Dentists and Meaningful Use: An Update
Dentists and Meaningful Use: An UpdateDentists and Meaningful Use: An Update
Dentists and Meaningful Use: An Update
 
Antenatal programme updates
Antenatal programme updatesAntenatal programme updates
Antenatal programme updates
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
 
SPHS at the IPC Group Meeting, USA
SPHS at the IPC Group Meeting, USASPHS at the IPC Group Meeting, USA
SPHS at the IPC Group Meeting, USA
 
ART At Cost Program
ART At Cost ProgramART At Cost Program
ART At Cost Program
 
Health Information Strategy Advisory Committee 2008
Health Information Strategy Advisory Committee 2008Health Information Strategy Advisory Committee 2008
Health Information Strategy Advisory Committee 2008
 
Intralign Rep-less Program
Intralign Rep-less ProgramIntralign Rep-less Program
Intralign Rep-less Program
 
Healthcare ERP Systems
Healthcare ERP SystemsHealthcare ERP Systems
Healthcare ERP Systems
 
Understanding about features and functions of electronic medical record software
Understanding about features and functions of electronic medical record softwareUnderstanding about features and functions of electronic medical record software
Understanding about features and functions of electronic medical record software
 
Building a Social Future for NCI Trials (W. Lawton)
Building a Social Future for NCI Trials (W. Lawton)Building a Social Future for NCI Trials (W. Lawton)
Building a Social Future for NCI Trials (W. Lawton)
 
Patient Engagement
Patient EngagementPatient Engagement
Patient Engagement
 
Involving patients to improve medication safety ismp canada
Involving patients to improve medication safety ismp canadaInvolving patients to improve medication safety ismp canada
Involving patients to improve medication safety ismp canada
 

Similar to Observational research and registries

Delivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and valueDelivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and valueKishan Patel, MBA
 
Connecting Patients, Providers and Payers John Halamka Keynote
Connecting Patients, Providers and Payers John Halamka KeynoteConnecting Patients, Providers and Payers John Halamka Keynote
Connecting Patients, Providers and Payers John Halamka Keynotemihinpr
 
Real World Late Phase The right approach for the right question
Real World Late Phase The right approach for the right questionReal World Late Phase The right approach for the right question
Real World Late Phase The right approach for the right questionSatish Kumar
 
Helen Figge Alere #MWC14 #mHealth
Helen Figge Alere #MWC14 #mHealthHelen Figge Alere #MWC14 #mHealth
Helen Figge Alere #MWC14 #mHealth3GDR
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014Dinesh T
 
CURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumCURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumMelanoma Research Foundation
 
Evoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_SundgrenEvoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_SundgrenMats Sundgren
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014Dinesh T
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014Dinesh T
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014Dinesh T
 
Deborah Weinswig's Digital Health Presentation for NACDS Aug. 24, 2015
Deborah Weinswig's Digital Health Presentation for NACDS Aug. 24, 2015Deborah Weinswig's Digital Health Presentation for NACDS Aug. 24, 2015
Deborah Weinswig's Digital Health Presentation for NACDS Aug. 24, 2015Deborah Weinswig
 
LTD introduction slides - Jan. 2016
LTD introduction slides - Jan. 2016LTD introduction slides - Jan. 2016
LTD introduction slides - Jan. 2016Yan Zhi
 
Cortellis for CTI external slides
Cortellis for CTI external slidesCortellis for CTI external slides
Cortellis for CTI external slidesMichael Passanante
 
[DSC Europe 23][DigiHealth] Haris Elhag Family health management system and c...
[DSC Europe 23][DigiHealth] Haris Elhag Family health management system and c...[DSC Europe 23][DigiHealth] Haris Elhag Family health management system and c...
[DSC Europe 23][DigiHealth] Haris Elhag Family health management system and c...DataScienceConferenc1
 
The Latest Regulations, Simplified: MU, PQRS & MIPS
The Latest Regulations, Simplified: MU, PQRS & MIPSThe Latest Regulations, Simplified: MU, PQRS & MIPS
The Latest Regulations, Simplified: MU, PQRS & MIPSathenahealth
 
Professor Dipak Kalra Digital Health Assembly 2015
Professor Dipak Kalra Digital Health Assembly 2015Professor Dipak Kalra Digital Health Assembly 2015
Professor Dipak Kalra Digital Health Assembly 2015DHA2015
 
Is mHealth Prescribing: Dead or Thriving?
Is mHealth Prescribing: Dead or Thriving?Is mHealth Prescribing: Dead or Thriving?
Is mHealth Prescribing: Dead or Thriving?AppScript
 
Global Discovery & Developement Innovation Forum 29016
Global Discovery & Developement Innovation Forum 29016Global Discovery & Developement Innovation Forum 29016
Global Discovery & Developement Innovation Forum 29016Mats Sundgren
 

Similar to Observational research and registries (20)

Delivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and valueDelivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and value
 
Connecting Patients, Providers and Payers John Halamka Keynote
Connecting Patients, Providers and Payers John Halamka KeynoteConnecting Patients, Providers and Payers John Halamka Keynote
Connecting Patients, Providers and Payers John Halamka Keynote
 
Real World Late Phase The right approach for the right question
Real World Late Phase The right approach for the right questionReal World Late Phase The right approach for the right question
Real World Late Phase The right approach for the right question
 
Helen Figge Alere #MWC14 #mHealth
Helen Figge Alere #MWC14 #mHealthHelen Figge Alere #MWC14 #mHealth
Helen Figge Alere #MWC14 #mHealth
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
CURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumCURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM Symposium
 
Evoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_SundgrenEvoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_Sundgren
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
Deborah Weinswig's Digital Health Presentation for NACDS Aug. 24, 2015
Deborah Weinswig's Digital Health Presentation for NACDS Aug. 24, 2015Deborah Weinswig's Digital Health Presentation for NACDS Aug. 24, 2015
Deborah Weinswig's Digital Health Presentation for NACDS Aug. 24, 2015
 
LTD introduction slides - Jan. 2016
LTD introduction slides - Jan. 2016LTD introduction slides - Jan. 2016
LTD introduction slides - Jan. 2016
 
Cortellis for CTI external slides
Cortellis for CTI external slidesCortellis for CTI external slides
Cortellis for CTI external slides
 
[DSC Europe 23][DigiHealth] Haris Elhag Family health management system and c...
[DSC Europe 23][DigiHealth] Haris Elhag Family health management system and c...[DSC Europe 23][DigiHealth] Haris Elhag Family health management system and c...
[DSC Europe 23][DigiHealth] Haris Elhag Family health management system and c...
 
0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols
 
The Latest Regulations, Simplified: MU, PQRS & MIPS
The Latest Regulations, Simplified: MU, PQRS & MIPSThe Latest Regulations, Simplified: MU, PQRS & MIPS
The Latest Regulations, Simplified: MU, PQRS & MIPS
 
Professor Dipak Kalra Digital Health Assembly 2015
Professor Dipak Kalra Digital Health Assembly 2015Professor Dipak Kalra Digital Health Assembly 2015
Professor Dipak Kalra Digital Health Assembly 2015
 
Theranos Biz Model
Theranos Biz ModelTheranos Biz Model
Theranos Biz Model
 
Is mHealth Prescribing: Dead or Thriving?
Is mHealth Prescribing: Dead or Thriving?Is mHealth Prescribing: Dead or Thriving?
Is mHealth Prescribing: Dead or Thriving?
 
Global Discovery & Developement Innovation Forum 29016
Global Discovery & Developement Innovation Forum 29016Global Discovery & Developement Innovation Forum 29016
Global Discovery & Developement Innovation Forum 29016
 

Observational research and registries

  • 1. Real-World & Late Phase Research The right approach for the right question Observational research & registries Initiatives AHRQ Registries User’s Guide – www.effectivehealthcare.ahrq.gov Quintiles leads the development of the Agency for Healthcare Research and Quality (AHRQ) user’s guide, Registries for Evaluating Patient Outcomes. AHRQ OCER User’s Guide – www.effectivehealthcare.ahrq.gov Quintiles leads the development of AHRQ user’s guide, Developing a Protocol for Observational Comparative Effectiveness Research. GRACE Principles – www.graceprinciples.org (Good ReseArch for Comparative Effectiveness) Quintiles develops quality evaluation principles for observational research. ROPR (Registry of Patient Registries) Quintiles leads the effort to create a central index of patient registries. ENCePP® – www.encepp.eu (European Network of Centres for Pharmacoepidemiology and Pharmacovigilance) Quintiles assists the monitoring of post-market medical products in Europe. PROTECT-EU – www.imi-protect.eu (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium) Quintiles helps develop innovative methods in pharmacoepidemiology and pharmacovigilance. ASTER-D (Adverse Event Spontaneous Triggered Electronic Reports for Devices) Quintiles participates in a pilot approach to collecting and transmitting adverse event data electronically. Connecting insights 950 Medical Doctors 900 PhDs 13 Therapeutic Centers of Excellence Superior delivery Quintiles named as Phase IV industry leader in ISR 2014 report amongst CRO Quality Benchmarking Phase IV Service Providers Better outcomes Quintiles helped develop or commercialize 100% of the Top 100 best-selling products or compounds of 2013 Quintiles is a Fortune 500 company Embrace value-based healthcare Turn clinical evidence and patient insight into a clear and convincing value story Maximize commercial value Achieve and sustain peak commercialization faster through better market access and channel strategies Achieve better patient outcomes Improve patient care using real-world measures and engagement Access global scale with local knowledge Leverage the industry’s largest integrated service infrastructure to gain local insight and market access
  • 2. Access to >18M Electronic Health Records through the COMPASS network Observational studies and quality improvement programs across >70,000 sites since 2004 Performed quality measurements for 13 patient associations and medical specialty associations since 2001 Quintiles has worked on 41 rare disease registries since 2004 Access to >61M patient lives via Electronic Health Records since 2004 125 patient registries and observational studies since 2011 >14.7M patients in observational and quality improvement programs in >100 countries since 2004 >2,500 hospitals in the American Heart Association's Get With The Guidelines® quality improvement program >400 direct-to- patient studies in >30 countries since 2008 >500 Real-World & Late Phase Programs since 2011 Experience of 44 post- authorization safety studies (PASS) >32,000 employees operating in more than 100 countries >14,500 HTA data records captured from 100 agencies in 32 countries Quintiles was named to InformationWeek Top 500 list of Information Technology Innovators for five consecutive years Quintiles has helped gain market access for >135 products in the U.S. since 2003 Copyright©2015Quintiles.Allrightsreserved.19.0011-1-02.15